Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease

Neurobiology of Disease

Volumn 32, Issue 3, 2008, Pages 471-478

  Lawhorn, Collene ^a   Smith, Diane M ^a   Brown, Lucy L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Basal ganglia; Behavior; Movement disorder; Striatum

Indexed keywords

CALBINDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CELL COMPARTMENTALIZATION; CELL COUNT; CELL LOSS; CELL ORGANELLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; GRIP STRENGTH; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MEASUREMENT; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; ROTAROD TEST; STRIOSOME; TASK PERFORMANCE; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; CELL DEATH; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY;

EID: 56449119791     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.08.006     Document Type: Article

References (65)

1. Aldridge J.W., and Berridge K.C. Coding of serial order by neostriatal neurons: a "natural action" approach to movement sequence. J. Neurosci. 18 7 (1998) 2777-2787
2. Arluison M., Dietl M., and Thibault J. Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: a topographical study. Brain Res. Bull. 13 2 (1984) 269-285
3. Bates G., Harper P., and Jones L. Huntingtons Disease (2002), Oxford University Press, Oxford
4. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., and Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321 6066 (1986) 168-171
5. Beal M.F., Ferrante R.J., Swartz K.J., and Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11 6 (1991) 1649-1659
6. Benn C.L., Slow E.J., Farrell L.A., Graham R., Deng Y., Hayden M.R., and Cha J.H. Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease. Neuroscience 147 2 (2007) 354-372
7. Breuer O., Lawhorn C., Miller T., Smith D.M., and Brown L.L. Functional architecture of the mammalian striatum: mouse vascular and striosome organization and their anatomic relationships. Neurosci. Lett. 385 3 (2005) 198-203
8. Brown L.L., Feldman S.M., Smith D.M., Cavanaugh J.R., Ackermann R.F., and Graybiel A.M. Differential metabolic activity in the striosome and matrix compartments of the rat striatum during natural behaviors. J. Neurosci. 22 1 (2002) 305-314
9. Canales J.J., and Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat. Neurosci. 3 4 (2000) 377-383
10. Choleris E., Thomas A.W., Kavaliers M., and Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci. Biobehav. Rev. 25 3 (2001) 235-260
11. Cicchetti F., Prensa L., Wu Y., and Parent A. Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease. Brain Res. Brain Res. Rev. 34 1-2 (2000) 80-101
12. Cromwell H.C., and Berridge K.C. Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax. J. Neurosci. 16 10 (1996) 3444-3458
13. Donoghue J.P., and Herkenham M. Neostriatal projections from individual cortical fields conform to histochemically distinct striatal compartments in the rat. Brain Res. 365 2 (1986) 397-403
14. Ferrante R.J., Kowall N.W., Beal M.F., Martin J.B., Bird E.D., and Richardson Jr. E.P. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 46 1 (1987) 12-27
15. Ferrante R.J., Gutekunst C.A., Persichetti F., McNeil S.M., Kowall N.W., Gusella J.F., MacDonald M.E., Beal M.F., and Hersch S.M. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 17 9 (1997) 3052-3063
16. Fotuhi M., Dawson T.M., Sharp A.H., Martin L.J., Graybiel A.M., and Snyder S.H. Phosphoinositide second messenger system is enriched in striosomes: immunohistochemical demonstration of inositol 1,4,5-trisphosphate receptors and phospholipase C beta and gamma in primate basal ganglia. J. Neurosci. 13 8 (1993) 3300-3308
17. Gerfen C.R., and Engber T.M. Molecular neuroanatomic mechanisms of Parkinson's disease: a proposed therapeutic approach. Neurol. Clin. 10 2 (1992) 435-449
18. Gerfen C.R., and Sawchenko P.E. An anterograde neuroanatomical tracing method that shows the detailed morphology of neurons, their axons and terminals: immunohistochemical localization of an axonally transported plant lectin, Phaseolus vulgaris leucoagglutinin (PHA-L). Brain Res. 290 2 (1984) 219-238
19. Gerfen C.R., and Sawchenko P.E. A method for anterograde axonal tracing of chemically specified circuits in the central nervous system: combined Phaseolus vulgaris-leucoagglutinin (PHA-L) tract tracing and immunohistochemistry. Brain Res. 343 1 (1985) 144-150
20. Graybiel A.M., and Ragsdale Jr. C.W. Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc. Natl. Acad. Sci. U. S. A. 75 11 (1978) 5723-5726
21. Groves P. A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Res. 286 2 (1983) 109-132
22. Gundersen H., and Jensen E. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147 Pt 3 (1987) 229-263
23. Gundersen H., P B., TF B., SM E., L K., N M., A M., K N., JR N., and B P. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96 10 (1988) 857-881
24. Hedreen J.C., and Folstein S.E. Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54 1 (1995) 105-120
25. Herkenham M., and Pert C.B. Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature 291 5814 (1981) 415-418
26. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., Smith D.J., Bissada N., McCutcheon K., Nasir J., Jamot L., Li X.J., Stevens M.E., Rosemond E., Roder J.C., Phillips A.G., Rubin E.M., Hersch S.M., and Hayden M.R. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23 1 (1999) 181-192
27. Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., and Celio M.R. Comparative Cytoarchitectonic Atlas of the c57bl/6 and 129/sv Mouse Brain (2000), Elsevier, Amsterdam
28. Jabourian M., Venance L., Bourgoin S., Ozon S., Perez S., Godeheu G., Glowinski J., and Kemel M.L. Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation. Eur. J. Neurosci. 21 12 (2005) 3301-3309
29. Krebs M.O., Trovero F., Desban M., Gauchy C., Glowinski J., and Kemel M.L. Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum. J. Neurosci. 11 5 (1991) 1256-1262
30. Liu F.C., and Graybiel A.M. Heterogeneous development of calbindin-D28K expression in the striatal matrix. J. Comp. Neurol. 320 3 (1992) 304-322
31. Menalled L.B., Sison J.D., Wu Y., Olivieri M., Li X.J., Li H., Zeitlin S., and Chesselet M.F. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J. Neurosci. 22 18 (2002) 8266-8276
32. Milnerwood A.J., and Raymond L.A. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load. J. Physiol. 585 Pt 3 (2007) 817-831
33. Miura M., Saino-Saito S., Masuda M., Kobayashi K., and Aosaki T. Compartment-specific modulation of GABAergic synaptic transmission by mu-opioid receptor in the mouse striatum with green fluorescent protein-expressing dopamine islands. J. Neurosci. 27 36 (2007) 9721-9728
34. Morton A.J., Nicholson L.F., and Faull R.L. Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease. Neuroscience 53 1 (1993) 159-168
35. Mouton P. Principles and Practices of Unbiased Stereology (2002), The Johns Hopkins University Press, Baltimore
36. Oorschot D. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical dissector methods. J. Comp. Neurol. 366 4 (1996) 580-599
37. Purdon S.E., Mohr E., Ilivitsky V., and Jones B.D. Huntington's disease: pathogenesis, diagnosis and treatment. J. Psychiatry Neurosci. 19 5 (1994) 359-367
38. Ragsdale Jr. C.W., and Graybiel A.M. Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat. J. Comp. Neurol. 269 4 (1988) 506-522
39. Rogers D.C., Fisher E.M., Brown S.D., Peters J., Hunter A.J., and Martin J.E. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 8 10 (1997) 711-713
40. Sax D.S., Powsner R., Kim A., Tilak S., Bhatia R., Cupples L.A., and Myers R.H. Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov. Disord. 11 6 (1996) 671-677
41. Seto-Ohshima A., Emson P.C., Lawson E., Mountjoy C.Q., and Carrasco L.H. Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 4 1 (1988) 1252-1255
42. Simon P., Dupuis R., and Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain Res. 61 1 (1994) 59-64
43. Slow E.J., van Raamsdonk J., Rogers D., Coleman S.H., Graham R.K., Deng Y., Oh R., Bissada N., Hossain S.M., Yang Y.Z., Li X.J., Simpson E.M., Gutekunst C.A., Leavitt B.R., and Hayden M.R. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12 13 (2003) 1555-1567
44. Sun Z., Wang H.B., Deng Y.P., Lei W.L., Xie J.P., Meade C.A., Del Mar N., Goldowitz D., and Reiner A. Increased calbindin-D(28k) immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice. Neurobiol. Dis 20 30 (2005) 907-917
45. Tang T.S., Slow E., Lupu V., Stavrovskaya I.G., Sugimori M., Llinas R., Kristal B.S., Hayden M.R., and Bezprozvanny I. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 102 7 (2005) 2602-2607
46. Tang T.S., Chen X., Liu J., and Bezprozvanny I. Dopaminergic signaling and striatal neurodegeneration in Huntington's disease. J. Neurosci. 27 30 (2007) 7899-7910
47. Tappe A., and Kuner R. Regulation of motor performance and striatal function by synaptic scaffolding proteins of the Homer1 family. Proc. Natl. Acad. Sci. U. S. A. 103 3 (2006) 774-779
48. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 6 (1993) 971-983
49. Tippett L.J., Waldvogel H.J., Thomas S.J., Hogg V.M., van Roon-Mom W., Synek B.J., Graybiel A.M., and Faull R.L. Striosomes and mood dysfunction in Huntington's disease. Brain 130 Pt 1 (2007) 206-221
50. Van Raamsdonk J.M., Murphy Z., Slow E.J., Leavitt B.R., and Hayden M.R. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 14 24 (2005) 3823-3835
51. Van Raamsdonk J.M., Pearson J., Slow E.J., Hossain S.M., Leavitt B.R., and Hayden M.R. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci. 25 16 (2005) 4169-4180
52. Van Raamsdonk J.M., Metzler M., Slow E., Pearson J., Schwab C., Carroll J., Graham R.K., Leavitt B.R., and Hayden M.R. Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain. Neurobiol. Dis. 26 1 (2007) 189-200
53. Van Raamsdonk J.M., Warby S.C., and Hayden M.R. Selective degeneration in YAC mouse models of Huntington disease. Brain Res. Bull. 72 2-3 (2007) 124-131
54. Vonsattel J.P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57 5 (1998) 369-384
55. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson Jr. E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 6 (1985) 559-577
56. Voorn P., Jorritsma-Byham B., Van Dijk C., and Buijs R.M. The dopaminergic innervation of the ventral striatum in the rat: a light- and electron-microscopical study with antibodies against dopamine. J. Comp. Neurol. 251 1 (1986) 84-99
57. Walker F.O. Huntington's disease. Semin. Neurol. 27 2 (2007) 143-150
58. Walker F.O. Huntington's disease. Lancet 369 9557 (2007) 218-228
59. West M. New stereological methods for counting neurons. Neurobiol. Aging 14 (1993) 275-285
60. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231 4 (1991) 482-497
61. White N.M., and Hiroi N. Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum. Proc. Natl. Acad. Sci. U. S. A. 95 11 (1998) 6486-6491
62. Wise R., and Colle L. Pimozide attenuates free feeding: best scores analysis reveals a motivational deficit. Psychopharmacology 66 (1984) 219-225
63. Wise R.A., and Raptis L. Effects of naloxone and pimozide on initiation and maintenance measures of free feeding. Brain Res. 368 1 (1986) 62-68
64. Zhu H., Lee M., Agatsuma S., and Hiroi N. Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice. Hum. Mol. Genet. 16 7 (2007) 820-836
65. Zimbelman J.L., Paulsen J.S., Mikos A., Reynolds N.C., Hoffmann R.G., and Rao S.M. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J. Int. Neuropsychol. Soc. 13 5 (2007) 758-769